OUP Management Co., LLC
- SEC CIK
- 0001880124
- Latest filing
- Nov 9, 2023
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Jul 19, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 15
- −1 vs. Q1 2022
- Portfolio value
- $72.7M
- −$58.7M (−44.7%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 2,937,615 | $14.3M | 19.7% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 989,232 | $14.1M | 19.4% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 603,762 | $9.44M | 13.0% | 00.0% | Unchanged | History |
| DICEDICE Therapeutics, Inc. | COM | 536,693 | $8.33M | 11.5% | 00.0% | Unchanged | History |
| CYTCyteir Therapeutics, Inc. | COM | 2,474,572 | $7.40M | 10.2% | 00.0% | Unchanged | History |
| IONQIonQ, Inc. | COM | 1,377,597 | $6.03M | 8.3% | −941,922−40.6% | Reduced | History |
| EVLVEvolv Technologies Holdings, Inc. | COM CL A | 1,582,721 | $4.21M | 5.8% | −238,145−13.1% | Reduced | History |
| VORVor Biopharma Inc. | COM | 374,714 | $1.86M | 2.6% | 00.0% | Unchanged | History |
| DTILPrecision Biosciences Inc | COM | 1,123,913 | $1.80M | 2.5% | 00.0% | Unchanged | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 1,025,697 | $1.46M | 2.0% | 00.0% | Unchanged | History |
| LABPLandos Biopharma, Inc. | COM | 1,612,764 | $1.17M | 1.6% | −214,714−11.7% | Reduced | History |
| RNACCartesian Therapeutics, Inc. | COM | 862,543 | $1.13M | 1.6% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 406,308 | $1.12M | 1.5% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 249,070 | $185.0K | 0.3% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 64,000 | $126.0K | 0.2% | 00.0% | Unchanged | History |
Sold out since Q1 2022 (1)
Positions held at the end of Q1 2022 that are gone from this filing.